Transdermal Skin Patch Market Report

Global Transdermal Skin Patch Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：138
  • REPORT CODE：GMM845584
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Transdermal Skin Patch market report explains the definition, types, applications, major countries, and major players of the Transdermal Skin Patch market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • Teva Pharmaceutical Industries Ltd

    • Hisamitsu Pharmaceutical

    • Luye Pharma Group Ltd

    • Novartis

    • Rfl Pharmaceutical

    • Mundipharma

    • Actavis

    • Teikoku Pharma

    • Changzhou Siyao

    • Henan Lingrui Pharmaceutical

    • Mylan

    • Purdue Pharma LP

    By Type:

    • Fentanyl Transdermal Skin Patch

    • Nicotine Transdermal Skin Patch

    • Clonidine Transdermal Skin Patch

    • Buprenorphine Transdermal Skin Patch

    By End-User:

    • Relieve Severe Pain

    • Stop Smoking Cigarettes

    • Treat An Overactive Bladder

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Transdermal Skin Patch Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Transdermal Skin Patch Outlook to 2028- Original Forecasts

    • 2.2 Transdermal Skin Patch Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Transdermal Skin Patch Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Transdermal Skin Patch Market- Recent Developments

    • 6.1 Transdermal Skin Patch Market News and Developments

    • 6.2 Transdermal Skin Patch Market Deals Landscape

    7 Transdermal Skin Patch Raw Materials and Cost Structure Analysis

    • 7.1 Transdermal Skin Patch Key Raw Materials

    • 7.2 Transdermal Skin Patch Price Trend of Key Raw Materials

    • 7.3 Transdermal Skin Patch Key Suppliers of Raw Materials

    • 7.4 Transdermal Skin Patch Market Concentration Rate of Raw Materials

    • 7.5 Transdermal Skin Patch Cost Structure Analysis

      • 7.5.1 Transdermal Skin Patch Raw Materials Analysis

      • 7.5.2 Transdermal Skin Patch Labor Cost Analysis

      • 7.5.3 Transdermal Skin Patch Manufacturing Expenses Analysis

    8 Global Transdermal Skin Patch Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Transdermal Skin Patch Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Transdermal Skin Patch Export by Region (Top 10 Countries) (2017-2028)

    9 Global Transdermal Skin Patch Market Outlook by Types and Applications to 2022

    • 9.1 Global Transdermal Skin Patch Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Fentanyl Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Nicotine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Clonidine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Buprenorphine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transdermal Skin Patch Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Relieve Severe Pain Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Stop Smoking Cigarettes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Treat An Overactive Bladder Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Transdermal Skin Patch Market Analysis and Outlook till 2022

    • 10.1 Global Transdermal Skin Patch Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Transdermal Skin Patch Consumption (2017-2022)

      • 10.2.2 Canada Transdermal Skin Patch Consumption (2017-2022)

      • 10.2.3 Mexico Transdermal Skin Patch Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.2 UK Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.3 Spain Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.4 Belgium Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.5 France Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.6 Italy Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.7 Denmark Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.8 Finland Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.9 Norway Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.10 Sweden Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.11 Poland Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.12 Russia Transdermal Skin Patch Consumption (2017-2022)

      • 10.3.13 Turkey Transdermal Skin Patch Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.2 Japan Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.3 India Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.4 South Korea Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.5 Pakistan Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.6 Bangladesh Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.7 Indonesia Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.8 Thailand Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.9 Singapore Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.10 Malaysia Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.11 Philippines Transdermal Skin Patch Consumption (2017-2022)

      • 10.4.12 Vietnam Transdermal Skin Patch Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.2 Colombia Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.3 Chile Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.4 Argentina Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.5 Venezuela Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.6 Peru Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.7 Puerto Rico Transdermal Skin Patch Consumption (2017-2022)

      • 10.5.8 Ecuador Transdermal Skin Patch Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Transdermal Skin Patch Consumption (2017-2022)

      • 10.6.2 Kuwait Transdermal Skin Patch Consumption (2017-2022)

      • 10.6.3 Oman Transdermal Skin Patch Consumption (2017-2022)

      • 10.6.4 Qatar Transdermal Skin Patch Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Transdermal Skin Patch Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Transdermal Skin Patch Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Transdermal Skin Patch Consumption (2017-2022)

      • 10.7.2 South Africa Transdermal Skin Patch Consumption (2017-2022)

      • 10.7.3 Egypt Transdermal Skin Patch Consumption (2017-2022)

      • 10.7.4 Algeria Transdermal Skin Patch Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Transdermal Skin Patch Consumption (2017-2022)

      • 10.8.2 New Zealand Transdermal Skin Patch Consumption (2017-2022)

    11 Global Transdermal Skin Patch Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Transdermal Skin Patch Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Transdermal Skin Patch Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Teva Pharmaceutical Industries Ltd

      • 11.2.1 Teva Pharmaceutical Industries Ltd Company Details

      • 11.2.2 Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Main Business and Markets Served

      • 11.2.4 Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Hisamitsu Pharmaceutical

      • 11.3.1 Hisamitsu Pharmaceutical Company Details

      • 11.3.2 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

      • 11.3.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Luye Pharma Group Ltd

      • 11.4.1 Luye Pharma Group Ltd Company Details

      • 11.4.2 Luye Pharma Group Ltd Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Luye Pharma Group Ltd Transdermal Skin Patch Main Business and Markets Served

      • 11.4.4 Luye Pharma Group Ltd Transdermal Skin Patch Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Transdermal Skin Patch Main Business and Markets Served

      • 11.5.4 Novartis Transdermal Skin Patch Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Rfl Pharmaceutical

      • 11.6.1 Rfl Pharmaceutical Company Details

      • 11.6.2 Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Rfl Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

      • 11.6.4 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Mundipharma

      • 11.7.1 Mundipharma Company Details

      • 11.7.2 Mundipharma Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Mundipharma Transdermal Skin Patch Main Business and Markets Served

      • 11.7.4 Mundipharma Transdermal Skin Patch Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Actavis

      • 11.8.1 Actavis Company Details

      • 11.8.2 Actavis Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Actavis Transdermal Skin Patch Main Business and Markets Served

      • 11.8.4 Actavis Transdermal Skin Patch Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Teikoku Pharma

      • 11.9.1 Teikoku Pharma Company Details

      • 11.9.2 Teikoku Pharma Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Teikoku Pharma Transdermal Skin Patch Main Business and Markets Served

      • 11.9.4 Teikoku Pharma Transdermal Skin Patch Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Changzhou Siyao

      • 11.10.1 Changzhou Siyao Company Details

      • 11.10.2 Changzhou Siyao Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Changzhou Siyao Transdermal Skin Patch Main Business and Markets Served

      • 11.10.4 Changzhou Siyao Transdermal Skin Patch Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Henan Lingrui Pharmaceutical

      • 11.11.1 Henan Lingrui Pharmaceutical Company Details

      • 11.11.2 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

      • 11.11.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Mylan

      • 11.12.1 Mylan Company Details

      • 11.12.2 Mylan Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Mylan Transdermal Skin Patch Main Business and Markets Served

      • 11.12.4 Mylan Transdermal Skin Patch Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Purdue Pharma LP

      • 11.13.1 Purdue Pharma LP Company Details

      • 11.13.2 Purdue Pharma LP Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Purdue Pharma LP Transdermal Skin Patch Main Business and Markets Served

      • 11.13.4 Purdue Pharma LP Transdermal Skin Patch Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Transdermal Skin Patch Market Outlook by Types and Applications to 2028

    • 12.1 Global Transdermal Skin Patch Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Fentanyl Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Nicotine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Clonidine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Buprenorphine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Transdermal Skin Patch Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Relieve Severe Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Stop Smoking Cigarettes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Treat An Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Transdermal Skin Patch Market Analysis and Outlook to 2028

    • 13.1 Global Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.2.2 Canada Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.2 UK Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.3 Spain Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.5 France Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.6 Italy Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.8 Finland Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.9 Norway Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.11 Poland Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.12 Russia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.2 Japan Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.3 India Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.3 Chile Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.6 Peru Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.6.3 Oman Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Transdermal Skin Patch Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Transdermal Skin Patch Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Transdermal Skin Patch Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Transdermal Skin Patch

    • Figure of Transdermal Skin Patch Picture

    • Table Global Transdermal Skin Patch Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Transdermal Skin Patch Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Fentanyl Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Nicotine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Clonidine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Buprenorphine Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Global Relieve Severe Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Stop Smoking Cigarettes Consumption and Growth Rate (2017-2022)

    • Figure Global Treat An Overactive Bladder Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Transdermal Skin Patch Consumption by Country (2017-2022)

    • Table North America Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure United States Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Canada Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Mexico Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table Europe Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure Germany Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure UK Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Spain Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Belgium Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure France Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Italy Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Denmark Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Finland Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Norway Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Sweden Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Poland Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Russia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Turkey Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table APAC Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure China Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Japan Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure India Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Thailand Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Singapore Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Philippines Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table South America Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure Brazil Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Colombia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Chile Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Argentina Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Peru Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table GCC Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure Bahrain Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Oman Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Qatar Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table Africa Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure Nigeria Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure South Africa Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Egypt Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure Algeria Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table Oceania Transdermal Skin Patch Consumption by Country (2017-2022)

    • Figure Australia Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Transdermal Skin Patch Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Transdermal Skin Patch Main Business and Markets Served

    • Table Johnson & Johnson Transdermal Skin Patch Product Portfolio

    • Table Teva Pharmaceutical Industries Ltd Company Details

    • Table Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Main Business and Markets Served

    • Table Teva Pharmaceutical Industries Ltd Transdermal Skin Patch Product Portfolio

    • Table Hisamitsu Pharmaceutical Company Details

    • Table Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hisamitsu Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

    • Table Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolio

    • Table Luye Pharma Group Ltd Company Details

    • Table Luye Pharma Group Ltd Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luye Pharma Group Ltd Transdermal Skin Patch Main Business and Markets Served

    • Table Luye Pharma Group Ltd Transdermal Skin Patch Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Transdermal Skin Patch Main Business and Markets Served

    • Table Novartis Transdermal Skin Patch Product Portfolio

    • Table Rfl Pharmaceutical Company Details

    • Table Rfl Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rfl Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

    • Table Rfl Pharmaceutical Transdermal Skin Patch Product Portfolio

    • Table Mundipharma Company Details

    • Table Mundipharma Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mundipharma Transdermal Skin Patch Main Business and Markets Served

    • Table Mundipharma Transdermal Skin Patch Product Portfolio

    • Table Actavis Company Details

    • Table Actavis Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Actavis Transdermal Skin Patch Main Business and Markets Served

    • Table Actavis Transdermal Skin Patch Product Portfolio

    • Table Teikoku Pharma Company Details

    • Table Teikoku Pharma Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teikoku Pharma Transdermal Skin Patch Main Business and Markets Served

    • Table Teikoku Pharma Transdermal Skin Patch Product Portfolio

    • Table Changzhou Siyao Company Details

    • Table Changzhou Siyao Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changzhou Siyao Transdermal Skin Patch Main Business and Markets Served

    • Table Changzhou Siyao Transdermal Skin Patch Product Portfolio

    • Table Henan Lingrui Pharmaceutical Company Details

    • Table Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Henan Lingrui Pharmaceutical Transdermal Skin Patch Main Business and Markets Served

    • Table Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Transdermal Skin Patch Main Business and Markets Served

    • Table Mylan Transdermal Skin Patch Product Portfolio

    • Table Purdue Pharma LP Company Details

    • Table Purdue Pharma LP Transdermal Skin Patch Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma LP Transdermal Skin Patch Main Business and Markets Served

    • Table Purdue Pharma LP Transdermal Skin Patch Product Portfolio

    • Figure Global Fentanyl Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nicotine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clonidine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Buprenorphine Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Relieve Severe Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stop Smoking Cigarettes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treat An Overactive Bladder Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Table North America Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure United States Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure Germany Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure China Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure Brazil Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Transdermal Skin Patch Consumption Forecast by Country (2022-2028)

    • Figure Australia Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Transdermal Skin Patch Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US